Clinical Trials

Docetaxel has been evaluated in numerous clinical trials spanning Phase 1 through Phase 4, including combination Phase 2/3 studies, to assess its efficacy as monotherapy and in combination regimens across indications such as non-small cell lung, prostate, breast, head and neck, and gastroesophageal cancers. Sponsored by government agencies like the National Cancer Institute, international research groups, academic institutions, and biopharmaceutical companies, these studies represent a comprehensive research effort. While many of these trials have reached completion, others remain active, recruiting, or scheduled for future initiation.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07667400 NOT_YET_RECRUITING
Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Paranasal Sinus Neoplasms; Nasopharyngeal Carcinoma; Oropharyngeal Squamous Cell Carcinoma; Hypopharyngeal Cancer; Carcinoma of Larynx; Oral Squamous Cell Carcinoma; Salivary Gland Cancer; Adenoid Cystic Carcinoma; Prostate Cancer; Metastatic Castration Resistant Prostate Cancer
National Cancer Institute (NCI)
 2026-09-09 PHASE1; PHASE2
NCT07645326 NOT_YET_RECRUITING
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Georgetown University
 2026-08 PHASE2
NCT06952504 RECRUITING
Endometrial Cancer
Merck Sharp & Dohme LLC
 2025-05-22 PHASE3
NCT06931340 RECRUITING
Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology
 2025-12-01 PHASE3
NCT06863272 RECRUITING
Castration-Resistant Prostatic Cancer; Metastasis
Merck Sharp & Dohme LLC
 2025-07-03 PHASE1; PHASE2
NCT06592924 RECRUITING
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group
 2025-05-28 PHASE3
NCT05919537 ACTIVE_NOT_RECRUITING
Non-Small Cell Lung Cancer; Pancreatic Cancer; Locally Advanced Solid Tumor; Metastatic Solid Tumor
Hummingbird Bioscience
 2023-09-06 PHASE1
NCT07365995 RECRUITING
Metastatic Castration-resistant Prostate Cancer
BioNTech SE
 2026-04-22 PHASE3
NCT07001618 RECRUITING
NSCLC (Advanced Non-small Cell Lung Cancer)
Gustave Roussy, Cancer Campus, Grand Paris
 2025-11-17 PHASE2
NCT07566052 RECRUITING
Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc.
 2026-04-28 PHASE3
NCT07668752 RECRUITING
KRAS G12D Mutation; NSCLC (Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc.
 2026-07-27 PHASE3
NCT07333066 RECRUITING
Metastatic Hormone-sensitive Prostate Cancer
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
 2026-06-05 PHASE3
NCT07795346 NOT_YET_RECRUITING
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Antengene Biologics Limited
 2026-09-01 PHASE3
NCT07518173 RECRUITING
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
 2026-04-21 PHASE3
NCT05538663 ACTIVE_NOT_RECRUITING
Non-muscle-invasive Bladder Cancer
ECOG-ACRIN Cancer Research Group
 2023-02-07 PHASE3
NCT07246863 RECRUITING
Metastatic Non-Squamous Non-Small Cell Lung Cancer; Adult Solid Tumor
CatalYm GmbH
 2025-10-07 PHASE2
NCT07419295 RECRUITING
Bladder Cancer
Merck Sharp & Dohme LLC
 2026-04-23 PHASE3
NCT07361484 NOT_YET_RECRUITING
Non-Small Cell Lung Cancer; Non-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc.
 2026-06-01 PHASE3
NCT06632327 ACTIVE_NOT_RECRUITING
Resectable Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8
Alliance for Clinical Trials in Oncology
 2024-12-11 PHASE3
NCT07417735 NOT_YET_RECRUITING
Locally Advanced/Metastatic/Recurrent ESCC
CSPC Megalith Biopharmaceutical Co.,Ltd.
 2026-03-18 PHASE3
NCT07730580 NOT_YET_RECRUITING
Advanced Prostate Cancer
Evopoint Biosciences Inc.
 2026-07-13 PHASE2
NCT06682780 RECRUITING
Advanced Solid Tumor
LaNova Medicines Limited
 2025-09-17 PHASE1; PHASE2
NCT06137378 RECRUITING
Squamous Cell Carcinoma of Head and Neck; Hypopharyngeal Squamous Cell Carcinoma; Laryngeal Squamous Cell Carcinoma Stage III; Laryngeal Squamous Cell Carcinoma Stage IV; Squamous Cell Carcinoma of Larynx; Squamous Cell Carcinoma of the Larynx; Squamous Cell Carcinoma of the Larynx Stage III; Squamous Cell Carcinoma of the Larynx Stage IV; Laryngeal Squamous Cell Carcinoma; Laryngectomy; Status; Laryngeal Cancer; Laryngeal Neoplasms
University of Leipzig
 2024-04-17 PHASE2
NCT06699212 RECRUITING
Recurrent Head and Neck Squamous Cell Carcinoma
Rakuten Medical, Inc.
 2024-12-24 PHASE3
NCT06795503 NOT_YET_RECRUITING
Triple-negative Breast Cancer
Fudan University
 2025-02 PHASE3
NCT07102940 NOT_YET_RECRUITING
Breast Cancer; HER 2 Negative Breast Cancer; HR Positive/HER-2 Negative Breast Cancer; Stage 1-3
George Washington University
 2026-09-01 PHASE2
NCT06204614 ENROLLING_BY_INVITATION
Muscle Invasive Bladder Urothelial Carcinoma
Brigham and Women's Hospital
 2024-06-14 EARLY_PHASE1
NCT07797218 RECRUITING
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Shanghai Jiao Tong University School of Medicine
 2026-07-01 PHASE3
NCT01935778 RECRUITING
Gastric Cancer, Adjuvant Chemotherapy, XO
Asan Medical Center
 2013-10-02 PHASE3
NCT03678025 RECRUITING
Castration Levels of Testosterone; Metastatic Prostatic Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network
 2018-09-24 PHASE3
NCT06929286 RECRUITING
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center
 2025-04-11 PHASE3
NCT07287150 RECRUITING
Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche
 2026-03-11 PHASE2
NCT07723248 RECRUITING
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals
 2026-08-03 PHASE3
NCT04337580 RECRUITING
Prostate Cancer; Refractory Cancer; Castration Resistant Prostatic Cancer
Wake Forest University Health Sciences
 2021-03-05 PHASE2
NCT01154920 ACTIVE_NOT_RECRUITING
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
 2010-07-09 PHASE2
NCT06629597 ACTIVE_NOT_RECRUITING
Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.
 2024-12-31 PHASE3
NCT05910827 RECRUITING
Advanced or Metastatic Squamous Non-Small Cell Lung Cancer; Advanced Head and Neck Squamous Cell Carcinoma; Advanced Esophageal Squamous Cell Carcinoma; Cervical Squamous Cell Carcinoma; Advanced Cutaneous Squamous Cell Carcinoma; Nasopharyngeal Cancinoma (NPC); Squamous Cell Carcinoma
Hummingbird Bioscience
 2024-02-05 PHASE1; PHASE2
NCT07768189 NOT_YET_RECRUITING
Oropharyngeal Carcinoma (OPC)
Corbus Pharmaceuticals Inc.
 2026-09-20 PHASE3
NCT07220135 RECRUITING
Breast Cancer
University of Kansas Medical Center
 2025-11-14 PHASE2
NCT05296798 ACTIVE_NOT_RECRUITING
Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche
 2022-07-18 PHASE3
NCT07016737 ENROLLING_BY_INVITATION
Esophageal Squamous Cell Carcinoma (ESCC)
Ye jinjun
 2024-08-01 PHASE3
NCT05818683 RECRUITING
Metastatic Castration-resistant Prostate Neoplasms; Metastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC
 2023-04-26 PHASE1
NCT05189457 ACTIVE_NOT_RECRUITING
Prostate Cancer; Stage IV Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
 2022-01-25 PHASE2
NCT05096663 ACTIVE_NOT_RECRUITING
Advanced Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
SWOG Cancer Research Network
 2022-03-15 PHASE2; PHASE3
NCT03505320 ACTIVE_NOT_RECRUITING
Pharmacokinetics of Zolbetuximab; Gastric Cancer; Gastro-esophageal Junction (GEJ) Cancer; Pharmacokinetics of Oxaliplatin; Pharmacokinetics of Fluorouracil Bolus (5-FU)
Astellas Pharma Global Development, Inc.
 2018-06-29 PHASE2
NCT07112209 ENROLLING_BY_INVITATION
Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer
Zhujiang Hospital
 2023-11-06
NCT05420454 RECRUITING
Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2022-07-10 PHASE4
NCT04812366 RECRUITING
Prostate Cancer
University of British Columbia
 2021-09-21 PHASE2
NCT07007988 RECRUITING
Malignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
 2025-04-24 PHASE1
NCT06078709 RECRUITING
Clinical Stage I Esophageal Adenocarcinoma AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Mayo Clinic
 2023-11-20 PHASE2
NCT06421298 RECRUITING
Lung Cancer
Jinghui Wang
 2024-05-17 PHASE2
NCT07545044 NOT_YET_RECRUITING
HER2-positive Recurrent or Metastatic Breast Cancer
Shanghai JMT-Bio Inc.
 2026-05-30 PHASE2
NCT05999994 RECRUITING
Neoplasms; Child; Adolescent
Eli Lilly and Company
 2020-01-22 PHASE2
NCT05176483 RECRUITING
Renal Cell Carcinoma (RCC); Metastatic Castration-Resistant Prostate Cancer (mCRPC); Urothelial Carcinoma (UC); Solid Tumor; Hepatocellular Carcinoma (HCC); Non-small Cell Lung Cancer (NSCLC); Colorectal Cancer (CRC); Head and Neck Squamous Cell Carcinoma (HNSCC); Clear Cell Renal Cell Carcinoma (ccRCC); Non-Clear Cell Renal Cell Carcinoma (nccRCC); Drug-Drug Interaction (DDI)
Exelixis
 2021-12-14 PHASE1
NCT05644041 ACTIVE_NOT_RECRUITING
Urinary Bladder Cancer
University of Arizona
 2023-03-01 PHASE2
NCT01810913 SUSPENDED
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma; Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7; Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7; Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7; Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
National Cancer Institute (NCI)
 2013-03-22 PHASE2; PHASE3
NCT07330050 RECRUITING
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital
 2025-12-01 PHASE2
NCT06704191 RECRUITING
Non-Muscle Invasive Bladder Carcinoma; Stage 0a Bladder Cancer AJCC v8; Stage I Bladder Cancer AJCC v8; Stage 0is Bladder Cancer AJCC v8
Mayo Clinic
 2025-04-21 PHASE1; PHASE2
NCT05813015 RECRUITING
Locally Advanced Gastric Adenocarcinoma; Chemotherapy Effect
Zhejiang University
 2023-01-28 PHASE3
NCT05631262 ACTIVE_NOT_RECRUITING
Selected Subjects With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 2022-11-30 PHASE2
NCT06194734 RECRUITING
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.
 2024-02-05 PHASE3
NCT07716176 RECRUITING
Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2025-12-12 PHASE3
NCT06943820 RECRUITING
Non-small Cell Lung Cancer Stage IIIB/IV; Head and Neck Squamous Cell Carcinoma (HNSCC); Colorectal Adenocarcinoma; Advanced Solid Tumors
Akeso
 2025-05-21 PHASE1; PHASE2
NCT05281471 RECRUITING
Platinum-resistant Ovarian Cancer; Platinum-refractory Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; High-grade Serous Ovarian Cancer; Endometrioid Ovarian Cancer; Ovarian Clear Cell Carcinoma
Genelux Corporation
 2022-08-31 PHASE3
NCT06749886 RECRUITING
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
 2024-11-19 PHASE2
NCT06542731 ACTIVE_NOT_RECRUITING
Non-small Cell Lung Cancer
Ono Pharmaceutical Co., Ltd.
 2021-06-01 PHASE1
NCT07316686 RECRUITING
Prostate Cancer (Adenocarcinoma)
Instituto do Cancer do Estado de São Paulo
 2026-06-16 PHASE1
NCT06935409 ACTIVE_NOT_RECRUITING
Osteosarcoma
Hansoh BioMedical R&D Company
 2025-04-25 PHASE3
NCT07116824 NOT_YET_RECRUITING
HER2-positive Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
 2025-09-15 PHASE2
NCT04140526 ACTIVE_NOT_RECRUITING
Non Small Cell Lung Cancer; Advanced Solid Tumor; Metastatic Melanoma; Metastatic Head and Neck Carcinoma; Metastatic Renal Cell Carcinoma; Metastatic Colorectal Cancer; Sarcomas; Metastatic Prostate Cancer; Ovarian Cancer; Small Cell Lung Cancer; Metastatic Breast Cancer; Pancreas Cancer; Gastric Cancer; Esophageal Cancer; Gastroesophageal Junction Adenocarcinoma; Cervical Cancer; Adenoid Cystic Carcinoma; Salivary Gland Cancer; Urothelial Carcinoma
OncoC4, Inc.
 2020-09-16 PHASE1; PHASE2
NCT04375605 COMPLETED
Gastroesophageal Junction Adenocarcinoma
Universitätsmedizin Mannheim
 2020-06-03 PHASE3
NCT06929936 RECRUITING
Non-Small Cell Lung Cancer; Myelosuppression
The First Affiliated Hospital of Xiamen University
 2025-05-09 PHASE2
NCT06492941 NOT_YET_RECRUITING
Advanced Pancreatic Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
 2024-08-12 PHASE3
NCT05348577 ACTIVE_NOT_RECRUITING
Prostate Cancer
AstraZeneca
 2022-03-25 PHASE3
NCT04343885 ACTIVE_NOT_RECRUITING
Metastatic Hormone Naive Prostate Cancer
Peter MacCallum Cancer Centre, Australia
 2020-04-21 PHASE2
NCT04872985 ACTIVE_NOT_RECRUITING
Breast Cancer; Hormone-receptor Positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
 2021-04-20 PHASE2
NCT03326947 RECRUITING
Neoplasm Neck
Shanghai Jiao Tong University School of Medicine
 2018-01-01 PHASE2
NCT05627752 UNKNOWN
Prostate Cancer; Castrate Resistant Prostate Cancer
Zhongnan Hospital
 2024-06-01 PHASE2; PHASE3
NCT06016062 RECRUITING
Solid Tumor
RemeGen Co., Ltd.
 2023-09-14 PHASE1; PHASE2
NCT03919552 RECRUITING
Cisplatin; Carboplatin; NPC
Nanfang Hospital, Southern Medical University
 2018-01-31 PHASE3
NCT04819971 UNKNOWN
Stomach Cancer
The First Affiliated Hospital of Zhengzhou University
 2021-12-01 PHASE2
NCT06793813 RECRUITING
Stage IVB Lung Cancer; Non-Squamous
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
 2024-01-23 PHASE2
NCT05426486 ACTIVE_NOT_RECRUITING
HER2-positive Breast Cancer
Caigang Liu
 2022-05-23 PHASE2; PHASE3
NCT03582475 ACTIVE_NOT_RECRUITING
Bladder Small Cell Neuroendocrine Carcinoma; Castration-Resistant Prostate Carcinoma; Metastatic Bladder Urothelial Carcinoma; Metastatic Urethral Urothelial Carcinoma; Prostate Carcinoma Metastatic in the Bone; Prostate Neuroendocrine Neoplasm; Prostate Small Cell Carcinoma; Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8; Stage III Prostate Cancer AJCC v8; Stage III Urethral Cancer AJCC v8; Stage IV Bladder Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IV Urethral Cancer AJCC v8; Stage IVA Bladder Cancer AJCC v8; Stage IVB Bladder Cancer AJCC v8; Ureter Small Cell Carcinoma; Urothelial Carcinoma
Jonsson Comprehensive Cancer Center
 2019-01-11 PHASE1
NCT03070886 COMPLETED
Stage I Prostate Adenocarcinoma AJCC v7; Stage II Prostate Adenocarcinoma AJCC v7; Stage III Prostate Adenocarcinoma AJCC v7
NRG Oncology
 2017-04-05 PHASE2; PHASE3
NCT05754853 RECRUITING
Advanced or Metastatic Urothelium Cancer
Shanghai Miracogen Inc.
 2023-04-06 PHASE3
NCT05878028 UNKNOWN
Non-small Cell Lung Cancer
Quanli Gao
 2022-09-16 PHASE2
NCT06611137 RECRUITING
Laryngeal Cancer; Hypopharynx Cancer
Sun Yat-sen University
 2024-09-11 PHASE2
NCT03851640 RECRUITING
MCRPC
Hinova Pharmaceuticals Inc.
 2019-04-12 PHASE3
NCT04356170 COMPLETED
Cancer of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou
 2021-02-04 PHASE2
NCT05838066 RECRUITING
First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
Shanghai JMT-Bio Inc.
 2023-07-23 PHASE3
NCT05006794 TERMINATED
Solid Malignancies
Gilead Sciences
 2021-09-15 PHASE1
NCT05733351 TERMINATED
Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8
Emory University
 2023-08-03 PHASE1
NCT06360978 NOT_YET_RECRUITING
Head and Neck Cancer
Assiut University
 2024-04 PHASE2
NCT05252429 ACTIVE_NOT_RECRUITING
Effect of Drug
Hokkaido University Hospital
 2022-07-06 PHASE2
NCT06475417 UNKNOWN
Gastric Cancer
Tang-Du Hospital
 2024-05-24 PHASE2
NCT05625412 COMPLETED
Advanced Solid Tumors
Bristol-Myers Squibb
 2022-12-09 PHASE1
NCT00076310 COMPLETED
Head and Neck Cancer
M.D. Anderson Cancer Center
 2004-01-28 PHASE2
NCT03917381 ACTIVE_NOT_RECRUITING
Solid Tumors
Genmab
 2019-05-14 PHASE1; PHASE2
NCT02931890 ACTIVE_NOT_RECRUITING
Gastric Cancer
The Netherlands Cancer Institute
 2017-12-21 PHASE2
NCT06009627 COMPLETED
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
 2023-04-11 PHASE2; PHASE3
NCT04553692 TERMINATED
Solid Tumor; Colorectal Cancer; Non Hodgkin Lymphoma; Sarcoma; Chondrosarcoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Acute Myeloid Leukemia
IGM Biosciences, Inc.
 2020-09-23 PHASE1
NCT03264547 COMPLETED
Breast Cancer
Japan Breast Cancer Research Group
 2017-08-28 PHASE3
NCT03764540 TERMINATED
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM)
 2019-04-01 PHASE2
NCT04547907 RECRUITING
Breast Cancer,HER2-positive
Henan Cancer Hospital
 2020-09-18 PHASE3
NCT02512315 UNKNOWN
Nasopharyngeal Carcinoma
Sun Yat-sen University
 2015-08 PHASE3
NCT05960955 RECRUITING
Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Akeso
 2023-11-13 PHASE2
NCT05543629 TERMINATED
Advanced Solid Tumors; Non-small Cell Lung Cancer
Bristol-Myers Squibb
 2022-10-04 PHASE1; PHASE2
NCT04781686 UNKNOWN
Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma
Zhou Fuxiang
 2021-05-14 PHASE2
NCT04256707 COMPLETED
Non-Small Cell Lung Carcinoma (NSCLC); Colorectal Cancer (CRC); Other Solid Tumors
Karyopharm Therapeutics Inc
 2020-01-14 PHASE1; PHASE2
NCT07435311 COMPLETED
Head and Neck Squamous Cell Carcinoma
R-Pharm
 2020-06-15 PHASE1
NCT04187898 COMPLETED
Neutropenia; Breast Cancer
Spectrum Pharmaceuticals, Inc
 2020-03-11 PHASE1
NCT04351867 UNKNOWN
Stomach Neoplasms
LiNing
 2020-09 PHASE3
NCT00254384 COMPLETED
Recurrent Lung Non-Small Cell Carcinoma; Stage IA Lung Non-Small Cell Carcinoma AJCC v7; Stage IB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Non-Small Cell Cancer AJCC v7
M.D. Anderson Cancer Center
 2005-10-05 PHASE1
NCT06060587 WITHDRAWN
Prostate Cancer
Northwestern University
 2023-10-19 PHASE2
NCT03739710 COMPLETED
Neoplasms
GlaxoSmithKline
 2019-01-24 PHASE2
NCT06319313 Not yet recruiting
Squamous Cell Non-small Cell Lung Cancer
Shanghai JMT-Bio Inc.
 2024-05-01 Phase 2|Phase 3
NCT03390504 ACTIVE_NOT_RECRUITING
Urothelial Cancer
Janssen Research & Development, LLC
 2018-03-23 PHASE3
NCT04882241 COMPLETED
Gastric Cancer; Gastroesophageal Junction Cancer
Merck Sharp & Dohme LLC
 2020-07-29 PHASE3
NCT03588091 COMPLETED
HER2-positive Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
 2018-07-24 PHASE3
NCT06200558 Not yet recruiting
Prostate Cancer
Hospital of Macerata
 2024-01-31 --
NCT04364620 COMPLETED
NSCLC Stage IV
Alethia Biotherapeutics
 2021-02-23 PHASE2
NCT04685135 ACTIVE_NOT_RECRUITING
Metastatic Non Small Cell Lung Cancer; Advanced Non Small Cell Lung Cancer
Mirati Therapeutics Inc.
 2021-02-23 PHASE3
NCT07333976 COMPLETED
Prostate Cancer Metastatic Disease; Chemotherapy Induced Peripheral Neuropathy (CIPN); Neurotoxicity
Tri-Service General Hospital (TSGH)
 2020-01-05 PHASE2
NCT04139772 UNKNOWN
Metastatic Castration-resistent Prostate Cancer
National Cancer Institute, Naples
 2019-09-01 PHASE3
NCT05156372 Withdrawn
Prostate Cancer Metastatic|Castrate Resistant Prostate Cancer|Metastatic Prostate Cancer|Metastatic Prostate Adenocarcinoma
The University of Texas Health Science Center at San Antonio
 2023-12 Not Applicable
NCT05165225 ACTIVE_NOT_RECRUITING
Breast Cancer; HER2-low-expressing Breast Cancer; Hormone Receptor-positive Breast Cancer; Neoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
 2021-07-13 PHASE2
NCT04172259 ACTIVE_NOT_RECRUITING
Breast Cancer; Neoadjuvant Chemotherapy
Sun Yat-sen University
 2019-01-10 PHASE2
NCT05552807 UNKNOWN
Head and Neck Squamous Carcinoma
Sinocelltech Ltd.
 2022-06-15 PHASE1
NCT03976375 COMPLETED
Metastatic Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC
 2019-06-26 PHASE3
NCT03435250 TERMINATED
Advanced Solid Tumors; Lymphoma
Institut de Recherches Internationales Servier
 2018-03-04 PHASE1
NCT05322499 UNKNOWN
Stage IV Esophagus Squamous Cell Carcinoma
Zhejiang Cancer Hospital
 2022-04-15 PHASE2
NCT04846634 NOT_YET_RECRUITING
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
 2021-08 PHASE2
NCT04427072 TERMINATED
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals
 2020-09-25 PHASE3
NCT04471675 UNKNOWN
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
 2020-12-02 PHASE1
NCT04306900 COMPLETED
Solid Tumor, Adult
Trishula Therapeutics, Inc.
 2020-03-30 PHASE1
NCT03881878 UNKNOWN
HER2-positive Breast Cancer
Samsung Medical Center
 2019-05-27 PHASE1; PHASE2
NCT05084859 TERMINATED
Castration-resistant Prostate Cancer; Non-small Cell Lung Cancer; Colorectal Cancer
Biosplice Therapeutics, Inc.
 2021-11-03 PHASE1
NCT03043807 COMPLETED
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
 2017-02-22 PHASE2
NCT04386746 ACTIVE_NOT_RECRUITING
Urothelial Carcinoma Bladder; Bladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
 2020-07-29 PHASE2
NCT04878107 UNKNOWN
Non-Small Cell Lung Cancer
Wuhan University
 2022-03-15 PHASE2
NCT04354662 COMPLETED
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
 2020-05-25 PHASE2
NCT04260360 WITHDRAWN
Renal Cell Carcinoma; Kidney Cancer; Adenocarcinoma of Kidney; Adenocarcinoma, Renal; Renal Cell Cancer
NanOlogy, LLC
 2020-04 PHASE1
NCT04414566 UNKNOWN
Nasopharyngeal Carcinoma
West China Hospital
 2020-06-01 PHASE3
NCT03839823 COMPLETED
Breast Cancer
Novartis Pharmaceuticals
 2019-02-25 PHASE2
NCT03737123 TERMINATED
Urothelial Carcinoma
Nabil Adra
 2018-12-19 PHASE2
NCT03061643 UNKNOWN
Prostatic Neoplasm
Samsung Medical Center
 2017-02-08 PHASE2
NCT04296747 UNKNOWN
Hypopharyngeal Squamous Cell Carcinoma
Peking Union Medical College Hospital
 2020-03 PHASE2
NCT04863248 TERMINATED
Metastatic Non-Small Cell Lung Cancer; NSCLC; Lung Cancer
G1 Therapeutics, Inc.
 2021-04-30 PHASE2
NCT03066154 TERMINATED
Prostatic Neoplasms
The Netherlands Cancer Institute
 2016-09 PHASE1
NCT02229149 TERMINATED
Breast Neoplasms; Malignant Tumor of the Breast
US Oncology Research
 2014-12 PHASE2
NCT02268695 COMPLETED
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou
 2014-10-10 PHASE2
NCT02555358 COMPLETED
Gastric Cancer
Qun Zhao
 2014-11 PHASE2
NCT04810208 TERMINATED
Solid Tumor
Lidds AB
 2019-02-28 PHASE1
NCT03643107 COMPLETED
Metastatic Castration-Resistant Prostate Cancer Patients
Allarity Therapeutics
 2018-10-17 PHASE2
NCT01779050 TERMINATED
Breast Neoplasms
Washington University School of Medicine
 2013-12-19 PHASE2
NCT03517969 ACTIVE_NOT_RECRUITING
Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8
National Cancer Institute (NCI)
 2019-05-29 PHASE2
NCT03358563 COMPLETED
Prostate Cancer
University of Wisconsin, Madison
 2018-01-17 EARLY_PHASE1
NCT03944980 UNKNOWN
IIIB/IIIC/IV Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
 2019-06-01 PHASE3
NCT03356912 UNKNOWN
Prostate Cancer; Castration-resistant Prostate Cancer
Consorzio Oncotech
 2017-11-22 PHASE2
NCT02001168 UNKNOWN
Non-small Cell Lung Cancer
Xinjiang Medical University
 2013-10 PHASE3
NCT02627807 UNKNOWN
Nasopharyngeal Neoplasms
Sun Yat-sen University
 2015-12
NCT03750916 UNKNOWN
Non Small Cell Lung Cancer
Qilu Hospital of Shandong University
 2018-11-30 PHASE2
NCT02531737 COMPLETED
Lung Neoplasms
University Hospital, Limoges
 2015-09 PHASE2
NCT03294577 UNKNOWN
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc.
 2019-10-23 PHASE3
NCT02447406 COMPLETED
Advanced Gastric Adenocarcinoma
Samsung Medical Center
 2015-04-30 PHASE1; PHASE2
NCT03209206 UNKNOWN
Urothelial Carcinoma
Seoul National University Hospital
 2017-06-28 PHASE2
NCT05084456 WITHDRAWN
Solid Tumor, Adult; Impaired Liver Function
Modra Pharmaceuticals
 2017-07 PHASE1
NCT01920061 COMPLETED
Neoplasm
Pfizer
 2013-09-10 PHASE1
NCT02610556 UNKNOWN
Nasopharyngeal Carcinoma
Sun Yat-sen University
 2016-01 PHASE2
NCT03002064 UNKNOWN
Esophagus Cancer; Chemotherapy Effects
Sun Yat-sen University
 2016-12 PHASE3
NCT02668393 COMPLETED
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim
 2016-03-07 PHASE1
NCT03703596 UNKNOWN
Lung Cancer; Lung Cancer Metastatic
Sichuan Cancer Hospital and Research Institute
 2018-10-16 PHASE2
NCT03949634 UNKNOWN
Early Breast Cancer
Fudan University
 2017-09-01 PHASE3
NCT03654027 UNKNOWN
Non-small Cell Lung Cancer
First Affiliated Hospital of Guangxi Medical University
 2018-10-01 PHASE2
NCT03269162 UNKNOWN
NSCLC
lihegen
 2016-09-30 PHASE3
NCT01572038 COMPLETED
Breast Neoplasms
Hoffmann-La Roche
 2012-06-01 PHASE3
NCT02813785 COMPLETED
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche
 2016-07-01 PHASE3
NCT02177552 UNKNOWN
Esophageal Neoplasms; Stomach Neoplasms
Rigshospitalet, Denmark
 2014-06 PHASE2
NCT03493854 COMPLETED
Early Breast Cancer
Hoffmann-La Roche
 2018-06-14 PHASE3
NCT03093272 TERMINATED
Prostate Cancer
Dana-Farber Cancer Institute
 2017-06-23 PHASE2
NCT02485691 COMPLETED
Prostate Cancer Metastatic
Sanofi
 2015-11-09 PHASE4
NCT02568839 ACTIVE_NOT_RECRUITING
Early-Stage Breast Carcinoma; HER-2 Positive Breast Cancer
Thomas Hatschek
 2014-11 PHASE2; PHASE3
NCT02909751 COMPLETED
Breast Cancer
Vejle Hospital
 2016-09-14 PHASE2
NCT03330106 COMPLETED
Advanced Solid Neoplasm
Millennium Pharmaceuticals, Inc.
 2017-11-15 PHASE1
NCT02884479 UNKNOWN
Advanced Solid Tumor; Non-Small Cell Lung Cancer
SciClone Pharmaceuticals International (Cayman) Development Limited
 2016-08 PHASE1; PHASE2
NCT03061058 UNKNOWN
Stomach Neoplasms; Chemotherapy Effect; Chemotherapeutic Toxicity
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2013-04-01 PHASE3
NCT02445586 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2015-08-17 PHASE4
NCT03574649 WITHDRAWN
Non Small Cell Lung Cancer
ImmunityBio, Inc.
 2018-06 PHASE2
NCT02194166 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2014-07-18 PHASE3
NCT02793765 WITHDRAWN
Prostate Cancer
The University of Texas Health Science Center, Houston
 2016-12 PHASE2
NCT02896855 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2016-09-13 PHASE3
NCT02779608 UNKNOWN
Stomach Neoplasms; Peritoneal Metastasis
Fudan University
 2017-01-20 PHASE2
NCT01693432 UNKNOWN
Esophageal Neoplasms
Hallym University Medical Center
 2011-11 PHASE2
NCT01503905 UNKNOWN
Breast Cancer Nos Premenopausal
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
 2011-12
NCT02508246 COMPLETED
Head and Neck Squamous Cell Carcinoma
University of Washington
 2015-07-22 PHASE1
NCT03425656 COMPLETED
Malignant Neoplasm of Breast
AryoGen Pharmed Co.
 2016-07-09 PHASE3
NCT02126969 COMPLETED
Head and Neck Cancer; Larynx
Susanne Arnold
 2014-10 PHASE2
NCT01376310 TERMINATED
Cancer
Novartis Pharmaceuticals
 2010-11-02 PHASE2
NCT03071042 UNKNOWN
Metastatic Gastric Adenocarcinoma
Sir Run Run Shaw Hospital
 2015-10 PHASE1
NCT02959749 COMPLETED
Progression Free Survival
Qingdao Central Hospital
 2015-08 PHASE2; PHASE3
NCT02494713 TERMINATED
Prostate Cancer
The University of Texas Health Science Center, Houston
 2015-10 PHASE2
NCT02560051 TERMINATED
Prostatic Neoplasms
The University of Texas Health Science Center, Houston
 2015-11 PHASE2
NCT02403531 COMPLETED
Neoplasms
Mian XI
 2015-05-01 PHASE2
NCT01862081 COMPLETED
Breast Cancer, Non-small Lung Cancer
Genentech, Inc.
 2013-07-16 PHASE1
NCT02985255 UNKNOWN
Tongue Neoplasms; Squamous Cell Carcinoma; Anterior Tongue Squamous Cell Carcinoma
HealthCare Global Enterprise Ltd.
 2016-04 PHASE2
NCT00630032 COMPLETED
Breast Cancer
UNICANCER
 2007-09 PHASE3
NCT02426125 COMPLETED
Urothelial Carcinoma
Eli Lilly and Company
 2015-07-13 PHASE3
NCT00828386 TERMINATED
Nasopharyngeal Cancers
Groupe Oncologie Radiotherapie Tete et Cou
 2009-01 PHASE3
NCT01803503 UNKNOWN
Solid Tumors; Breast Cancer; Non-small Cell Lung Cancer; Prostate Cancer; Gastric Cancer
National University Hospital, Singapore
 2013-05 PHASE2
NCT02947061 UNKNOWN
Breast Cancer Recurrent
Chinese Academy of Medical Sciences
 2015-04 PHASE2
NCT02326285 TERMINATED
Non-squamous Non-small Cell Lung Cancer Stage II; Non-squamous Non-small Cell Lung Cancer Stage IIIA; Non-squamous Non-small Cell Lung Cancer Stage IIIB; Activating EGFR Mutation; NSCLC
AIO-Studien-gGmbH
 2015-11 PHASE2; PHASE3
NCT02439346 TERMINATED
Medical Oncology
Bayer
 2015-06-15 PHASE1
NCT01876927 COMPLETED
Gastric Cancer; Locally Advanced Malignant Neoplasm
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
 2010-09 PHASE2
NCT02551055 TERMINATED
Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
Millennium Pharmaceuticals, Inc.
 2015-10-15 PHASE1
NCT00544414 COMPLETED
Head and Neck Cancer
City of Hope Medical Center
 2000-06-07 PHASE2
NCT02900742 COMPLETED
Cancer
Shanghai University of Traditional Chinese Medicine
 2013-03 PHASE3
NCT01174368 COMPLETED
Prostate Cancer
The Rogosin Institute
 2010-06 PHASE2
NCT02208583 UNKNOWN
Hormone Refractory Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital
 2014-06
NCT00117572 COMPLETED
Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Nasal Cavity; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
University of Chicago
 2004-11 PHASE3
NCT00945451 COMPLETED
Lung Cancer
Centre Antoine Lacassagne
 2009-04-24
NCT01932697 COMPLETED
Human Papillomavirus Infection; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Oropharyngeal Squamous Cell Carcinoma; Stage III Oropharyngeal Squamous Cell Carcinoma; Stage IVA Oropharyngeal Squamous Cell Carcinoma; Stage IVB Oropharyngeal Squamous Cell Carcinoma
Mayo Clinic
 2013-09-04 PHASE2
NCT02088515 COMPLETED
Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
 2013-12 PHASE4
NCT01882985 COMPLETED
Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer
University of California, Irvine
 2010-12 PHASE2
NCT04397341 COMPLETED
Locally Advanced Head and Neck Carcinoma
China Medical University Hospital
 2014-03-01 PHASE2
NCT02008227 COMPLETED
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche
 2014-03-11 PHASE3
NCT01933932 ACTIVE_NOT_RECRUITING
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca
 2013-09-25 PHASE3
NCT01891123 UNKNOWN
Non-small Cell Lung Cancer; Breast Cancer; Nasal Cancer
Sun Yat-sen University
 2013-06
NCT02099396 UNKNOWN
Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma
China Association of Osteosarcoma Chemotherapy
 2014-04 PHASE2; PHASE3
NCT04031703 COMPLETED
Breast Cancer
Fudan University
 2011-01-01 PHASE3
NCT01216111 COMPLETED
Triple Negative Breast Cancer
Fudan University
 2011-01-01 PHASE3
NCT02252913 COMPLETED
Gastric Cancer
Hutchison Medipharma Limited
 2014-09 PHASE1
NCT02182622 WITHDRAWN
Prostate Cancer
Martin Gutierrez
 2014-07 PHASE1
NCT01540110 COMPLETED
Breast Cancer
National Cancer Centre, Singapore
 2010-08-11 PHASE2
NCT00324805 COMPLETED
Stage IB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI)
 2007-07-19 PHASE3
NCT01485861 COMPLETED
Prostate Cancer
Genentech, Inc.
 2012-01-11 PHASE1; PHASE2
NCT01718353 COMPLETED
Prostate Cancer Metastatic
Sanofi
 2013-03 PHASE2
NCT00086957 COMPLETED
Breast Cancer
City of Hope Medical Center
 2004-01 PHASE1; PHASE2
NCT02005783 COMPLETED
Grade 3/4 Neutropenia; Febrile Neutropenia
Shanghai Jiao Tong University School of Medicine
 2013-10 PHASE2
NCT02216617 COMPLETED
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou
 2014-08-06 PHASE1
NCT01385228 COMPLETED
Prostate Cancer
Daniel George, MD
 2011-06 PHASE1
NCT01671332 COMPLETED
Carcinoma, Non Small Cell Lung
University of Wisconsin, Madison
 2012-06 PHASE2
NCT00478699 COMPLETED
Non-small-cell Lung Cancer
Spanish Lung Cancer Group
 2007-06 PHASE3
NCT01106352 COMPLETED
Bone Metastases; Castration-Resistant Prostate Cancer
Bayer
 2010-07 PHASE1; PHASE2
NCT00526110 COMPLETED
Gastrointestinal Diseases
M.D. Anderson Cancer Center
 2004-08 PHASE1; PHASE2
NCT01540253 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute
 2012-05 PHASE1
NCT01443078 COMPLETED
Lung Cancer
Memorial Sloan Kettering Cancer Center
 2011-10 PHASE2
NCT01812018 UNKNOWN
Soft Tissue Sarcoma
Peng Yuan
 2012-11 PHASE2
NCT01605916 COMPLETED
Neoplasms,; Metastatic Cancer,; Non-Small Cell Lung Cancer; Advanced Solid Malignancies
AstraZeneca
 2012-06 PHASE1
NCT01985841 TERMINATED
Breast Cancer
Hellenic Oncology Research Group
 2011-10 PHASE2
NCT01673867 COMPLETED
Non-Squamous Cell Non-small Cell Lung Cancer
Bristol-Myers Squibb
 2012-11-02 PHASE3
NCT00203502 COMPLETED
Breast Cancer
University of Arkansas
 2005-09 PHASE2
NCT02035124 WITHDRAWN
Advanced Prostate Cancer
SCRI Development Innovations, LLC
 2014-04 PHASE2
NCT00021255 COMPLETED
Breast Neoplasms
Sanofi
 2001-04 PHASE3
NCT01204307 COMPLETED
Advanced Non-Squamous Non-Small Cell Lung Cancer
Chang Gung Memorial Hospital
 2010-01 PHASE2
NCT01642004 COMPLETED
Squamous Cell Non-small Cell Lung Cancer
Bristol-Myers Squibb
 2012-10-16 PHASE3
NCT01220128 TERMINATED
Neoplasms, Breast
GlaxoSmithKline
 2011-04-11 PHASE2
NCT00952003 COMPLETED
Gastric Cancer; Unresectable
Arbeitsgemeinschaft medikamentoese Tumortherapie
 2009-07 PHASE2
NCT01754623 TERMINATED
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
 2013-02 PHASE2
NCT01472029 COMPLETED
Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach
AIO-Studien-gGmbH
 2011-12 PHASE2
NCT02223884 COMPLETED
Malignant Melanoma
Yonsei University
 2011-07 PHASE2
NCT01614938 UNKNOWN
Nasopharyngeal Carcinoma
Fudan University
 2010-08 PHASE2
NCT00721513 COMPLETED
Head and Neck Cancer
Wake Forest University Health Sciences
 2008-09 PHASE2
NCT01824901 COMPLETED
Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer
ECOG-ACRIN Cancer Research Group
 2014-01-15 PHASE1; PHASE2
NCT01172028 COMPLETED
Breast Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer
University of Arizona
 2005-09 PHASE1
NCT01695135 COMPLETED
Prostate Neoplasms
Janssen Research & Development, LLC
 2012-08-09 PHASE3
NCT00953420 COMPLETED
Nasopharyngeal Carcinoma
Baylor College of Medicine
 2009-11 PHASE2
NCT01467115 COMPLETED
Head and Neck Cancer
Drexel University College of Medicine
 2010-03 PHASE2
NCT01254513 COMPLETED
Prostate Cancer
UNICANCER
 2010-12-09 PHASE2
NCT01424709 UNKNOWN
Non-small Cell Lung Cancer
Tongji University
 2010-12 PHASE2
NCT01362400 COMPLETED
Non Small Cell Lung Cancer
Infinity Pharmaceuticals, Inc.
 2011-05 PHASE2
NCT02105675 COMPLETED
Prostate Cancer; Prostate Cancer Metastatic
SOTIO a.s.
 2012-02 PHASE2
NCT00669773 UNKNOWN
Breast Cancer
National University Hospital, Singapore
 2007-02 PHASE2
NCT00309985 COMPLETED
Metastatic Hormone-sensitive Prostate Cancer
ECOG-ACRIN Cancer Research Group
 2006-09-26 PHASE3
NCT01536223 UNKNOWN
Chemoradiation; Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
 2012-04 PHASE3
NCT00321334 COMPLETED
Non-small Cell Lung Cancer
Chinese Society of Lung Cancer
 2006-03 PHASE3
NCT00769470 COMPLETED
Breast Cancer
Translational Oncology Research International
 2009-04 PHASE2
NCT01747707 UNKNOWN
Gastric Cancer; Gastroesophageal Junction Cancer
Chinese Academy of Medical Sciences
 2012-09 PHASE2
NCT01300533 COMPLETED
Metastatic Cancer; Cancer; Solid Tumors
BIND Therapeutics
 2011-01 PHASE1
NCT01880385 UNKNOWN
Inflammatory Breast Cancer
Association Tunisienne de lutte Contre le Cancer
 2011-03 PHASE1
NCT01378091 COMPLETED
Prostate Cancer
Columbia University
 2005-08 PHASE1
NCT00621049 COMPLETED
Non-Small Cell Lung Cancer
SCRI Development Innovations, LLC
 2007-12 PHASE2
NCT00450892 COMPLETED
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
 2007-02 PHASE1; PHASE2
NCT01131429 UNKNOWN
Neoplasms, Lung; Carcinoma, Non-Small Cell Lung; Drug Therapy; Genes, EGFR
Chinese PLA General Hospital
 2010-06 PHASE2
NCT01356368 TERMINATED
Non-Small Cell Lung Cancer
National Guard Health Affairs
 2010-05 PHASE2
NCT01234025 COMPLETED
Castrate-Resistant Prostate Cancer
Ionis Pharmaceuticals, Inc.
 2010-11 PHASE1; PHASE2
NCT01352494 UNKNOWN
Breast Cancer Stage II; Breast Cancer Stage III
Korean Breast Cancer Study Group
 2011-05 PHASE2
NCT01671319 COMPLETED
Female Breast Cancer
University of Wisconsin, Madison
 2011-06 PHASE2
NCT00179309 COMPLETED
Breast Cancer
National Cancer Institute (NCI)
 2005-09 PHASE2
NCT00927589 COMPLETED
Solid Cancers
Genentech, Inc.
 2009-07 PHASE1
NCT01685983 COMPLETED
Prostate Cancer
Janssen Research & Development, LLC
 2011-08-30 PHASE2
NCT00949247 COMPLETED
Breast Cancer
Case Comprehensive Cancer Center
 2009-12 EARLY_PHASE1
NCT01243775 COMPLETED
Non-Small Cell Lung Cancer
Chonnam National University Hospital
 2010-11 PHASE2
NCT01285635 TERMINATED
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
University of Michigan Rogel Cancer Center
 2010-06 PHASE2
NCT01073683 UNKNOWN
Larynx Cancer
Rabin Medical Center
 2010-04 PHASE2
NCT00201825 COMPLETED
Lung Cancer; Non-Small-Cell Lung Carcinoma
Tony Bekaii-Saab
 2004-12 PHASE2
NCT01038752 TERMINATED
Non-small Cell Lung Cancer
Optimum Therapeutics, LLC
 2010-08 PHASE2
NCT01138163 COMPLETED
Non-small-cell Lung Cancer
Peregrine Pharmaceuticals
 2010-06 PHASE2
NCT00771563 COMPLETED
Non-Small Cell Lung Cancer
University Hospital, Antwerp
 2008-06 PHASE3
NCT01155791 TERMINATED
Urologic Neoplasms; Prostate Cancer; Prostate Cancer Metastatic Disease
Sandy Srinivas
 2010-04 PHASE1
NCT00301808 COMPLETED
Lung Cancer
Barbara Ann Karmanos Cancer Institute
 2005-11 PHASE2
NCT00514917 TERMINATED
Prostatic Neoplasms
Sanofi
 2007-07 PHASE3
NCT01362296 COMPLETED
Lung Cancer, Non-Small Cell
GlaxoSmithKline
 2011-09 PHASE2
NCT00744497 COMPLETED
Prostatic Neoplasms
Bristol-Myers Squibb
 2008-10 PHASE3
NCT00995761 COMPLETED
Non-small Cell Lung Cancer
Gyeongsang National University Hospital
 2009-10 PHASE2
NCT00944424 UNKNOWN
Breast Cancer
King Faisal Specialist Hospital & Research Center
 2009-07 PHASE3
NCT01530295 UNKNOWN
Prostate Cancer
Hanjong Ahn
 2008-07
NCT00454779 COMPLETED
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Amgen
 2007-01-01 PHASE2
NCT00816543 COMPLETED
Gastric Cancer
Sanofi
 2008-12 PHASE2
NCT00888108 COMPLETED
Solid Tumor
Abbott
 2009-07 PHASE1
NCT00343239 COMPLETED
Stomach Neoplasms
Sanofi
 2006-06 PHASE2
NCT00704821 TERMINATED
Advanced Cancer
PTC Therapeutics
 2008-07-03 PHASE1
NCT00665392 COMPLETED
Head and Neck Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
 2008-02-01 PHASE2
NCT01069081 COMPLETED
Breast Cancer; Metastasis, Neoplasm
Fudan University
 2009-08 PHASE2
NCT01229605 WITHDRAWN
Breast Cancer
Tufts Medical Center
 2010-10 PHASE2
NCT01044485 COMPLETED
Metastatic Breast Cancer
Centre Georges Francois Leclerc
 2008-11 PHASE1; PHASE2
NCT01478308 WITHDRAWN
Prostate Cancer
New Mexico Cancer Research Alliance
 2011-06 PHASE2
NCT00551759 TERMINATED
Esophageal Cancer
Eastern Cooperative Oncology Group
 2008-10-02 PHASE2
NCT00794547 TERMINATED
Non Small Cell Lung Cancer
University of Michigan Rogel Cancer Center
 2008-12 PHASE1; PHASE2
NCT00485303 COMPLETED
Prostatic Neoplasms; Prostate Cancer
Cougar Biotechnology, Inc.
 2007-06 PHASE2
NCT00976976 COMPLETED
Resected Advanced Gastric Cancer
Asan Medical Center
 2007-05 PHASE2
NCT01103791 COMPLETED
Advanced Solid Malignancies
Samyang Biopharmaceuticals Corporation
 2010-04 PHASE1
NCT00474383 COMPLETED
Prostate Neoplasms
Cougar Biotechnology, Inc.
 2006-11 PHASE2
NCT00296816 COMPLETED
Ovarian Cancer
Sanofi
 2006-03 PHASE2
NCT00976989 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2009-11 PHASE2
NCT00848718 COMPLETED
Locally Advanced, Metastatic Solid Tumors
Merck Sharp & Dohme LLC
 2009-03-17 PHASE1
NCT00795171 UNKNOWN
Hormone Refractory Prostate Cancer
Medical University of Vienna
 2008-11 PHASE2
NCT00748358 COMPLETED
Prostatic Neoplasms; Neoplasms, Hormone-Dependent; Tumor Markers, Biological; Survival Rate; Disease-Free Survival
Assistance Publique - Hôpitaux de Paris
 2008-03 PHASE2
NCT00169247 COMPLETED
Larynx Cancer; Hypopharynx Cancer
Groupe Oncologie Radiotherapie Tete et Cou
 2005-10 PHASE2
NCT00313781 COMPLETED
Prostatic Neoplasms
Pfizer
 2006-05 PHASE2
NCT00436501 COMPLETED
Fallopian Tube Cancer; Malignant Tumor of Peritoneum; Recurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI)
 2007-01 PHASE1; PHASE2
NCT00099086 COMPLETED
Prostate Cancer
Medical University of South Carolina
 2007-01-16 PHASE1
NCT00687297 COMPLETED
Lung Cancer; Non Small Cell Lung Cancer
PrECOG, LLC.
 2008-04 PHASE2
NCT00820872 COMPLETED
Breast Cancer
Alliance for Clinical Trials in Oncology
 2009-02 PHASE2
NCT00840125 COMPLETED
Non-Small Cell Lung Cancer
Meir Medical Center
 2009-02 PHASE2
NCT01240642 TERMINATED
Metastatic Cancer With Impaired Renal Function; Metastatic Cancer With Normal Renal Function
Novartis Pharmaceuticals
 2010-01 PHASE1
NCT00513383 COMPLETED
Squamous Cell Carcinoma of the Head and Neck
Massachusetts General Hospital
 2006-04 PHASE1
NCT00848601 TERMINATED
Prostate Cancer; Non-Hodgkins Lymphoma
Astex Pharmaceuticals, Inc.
 2009-02 PHASE1
NCT00559754 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2007-12 PHASE2
NCT01019941 COMPLETED
Advanced Solid Cancers
Chong Kun Dang Pharmaceutical
 2009-08 PHASE1
NCT00915850 UNKNOWN
Esophageal Cancer
Wakayama Medical University
 2007-08 PHASE1; PHASE2
NCT00813072 COMPLETED
Stomach Neoplasms; Esophageal Neoplasms
PharmaEngine
 2007-11 PHASE2
NCT00833326 COMPLETED
Advanced Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer
 2009-01 PHASE1
NCT00520676 COMPLETED
Non-Small Cell Lung Cancer
Eli Lilly and Company
 2007-10 PHASE3
NCT00261703 COMPLETED
Head and Neck Neoplasms
Sanofi
 2002-12 PHASE2; PHASE3
NCT00911716 COMPLETED
Breast Cancer
Cancer Trials Ireland
 2008-10
NCT00598858 WITHDRAWN
Prostate Cancer; Adenocarcinoma of the Prostate; Stage I Prostate Cancer; Stage II Prostate Cancer
John P. Fruehauf
 2009-01 PHASE2
NCT00525005 COMPLETED
Stomach Neoplasms
Hallym University Medical Center
 2007-08 PHASE2
NCT00651326 TERMINATED
Prostate Cancer
NCIC Clinical Trials Group
 2008-06-02 PHASE3
NCT00861471 TERMINATED
Prostate Cancer; Prostatic Neoplasms
NYU Langone Health
 2005-05 PHASE1; PHASE2
NCT00978549 COMPLETED
Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer; Gastric Cancer; Nausea and Vomiting; Pain
Cambridge University Hospitals NHS Foundation Trust
 2008-04 PHASE3
NCT00077857 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2003-07 PHASE2
NCT00459043 COMPLETED
Squamous Cell Carcinoma of Head and Neck
Dana-Farber Cancer Institute
 2007-03 PHASE2
NCT00833859 TERMINATED
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute
 2009-03 PHASE2
NCT00514267 COMPLETED
Prostate Cancer; Tumors
Astellas Pharma Inc
 2007-05 PHASE1; PHASE2
NCT00227669 COMPLETED
Sarcoma
UNICANCER
 2005-10 PHASE2
NCT00876044 COMPLETED
Cancer
Sanofi
 2009-04 PHASE1
NCT00118131 TERMINATED
Lung Cancer
University of Medicine and Dentistry of New Jersey
 2003-12 PHASE2
NCT00073983 COMPLETED
Sarcoma
Sarcoma Alliance for Research through Collaboration
 2006-10 PHASE2
NCT00862134 TERMINATED
Non-Small Cell Lung Cancer
Proacta, Incorporated
 2009-03 PHASE2
NCT00399087 COMPLETED
Neoplasms
AEterna Zentaris
 2004-11 PHASE1
NCT00172380 COMPLETED
NSCLC
National Taiwan University Hospital
 2005-02 PHASE2
NCT01869192 COMPLETED
Malignant Neoplasm of Female Breast
University of Colorado, Denver
 2003-03-05 PHASE2
NCT00448734 UNKNOWN
Hormone Refractory Prostate Cancer
Poniard Pharmaceuticals
 2006-06 PHASE1; PHASE2
NCT00816816 UNKNOWN
Nasopharyngeal Carcinoma
Fudan University
 2007-02 PHASE2
NCT00464646 COMPLETED
Breast Cancer
NSABP Foundation Inc
 2007-05 PHASE2
NCT00209690 COMPLETED
Esophageal Cancer
Hokkaido Gastrointestinal Cancer Study Group
 2003-10 PHASE1; PHASE2
NCT00881166 COMPLETED
Malignant Disease
Astex Pharmaceuticals, Inc.
 2007-11 PHASE1
NCT00601692 COMPLETED
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
 2003-04 PHASE1
NCT00377559 COMPLETED
Breast Cancer; Neoplasm Metastasis
Catharina Ziekenhuis Eindhoven
 2006-05 PHASE2
NCT00209716 COMPLETED
Esophageal Cancer
Hokkaido Gastrointestinal Cancer Study Group
 2003-12 PHASE1; PHASE2
NCT00906061 UNKNOWN
Carcinoma, Non-Small-Cell Lung
Hospital Arnau de Vilanova
 2007-10 PHASE2
NCT00215930 COMPLETED
Carcinoma, Non-Small-Cell Lung
H. Lee Moffitt Cancer Center and Research Institute
 2004-02 PHASE2
NCT00466440 COMPLETED
Prostate Cancer
Eli Lilly and Company
 2007-06 PHASE2
NCT00308750 COMPLETED
Non-Small Cell Lung Cancer
Eli Lilly and Company
 2006-03 PHASE2
NCT00209092 COMPLETED
Breast Cancer
Emory University
 2006-08 PHASE2
NCT00705822 TERMINATED
Prostatic Neoplasms
Sanofi
 2006-08 PHASE3
NCT00088907 TERMINATED
Recurrent Head and Neck Cancer; Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
 2004-08 PHASE3
NCT00255606 COMPLETED
Prostate Cancer
Tampere University
 2005-08 PHASE3
NCT00372736 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group
 2006-07-27 PHASE1
NCT00313456 TERMINATED
Tumors; Prostate Cancer
Agennix
 2006-03 PHASE1
NCT01222052 UNKNOWN
Breast Cancer
Martin-Luther-Universität Halle-Wittenberg
 2002-01 PHASE3
NCT00426127 TERMINATED
Pancreatic Cancer
University of Iowa
 2006-11 PHASE2
NCT00711243 COMPLETED
Gastric Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Northwestern University
 2005-04-20 PHASE1; PHASE2
NCT00554918 COMPLETED
Metastatic Cancer; Prostate Cancer
University Hospital Birmingham
 2005-02 PHASE2
NCT00193037 COMPLETED
Breast Cancer
SCRI Development Innovations, LLC
 2001-02 PHASE2
NCT00191152 COMPLETED
Breast Cancer; Breast Neoplasms; Cancer of the Breast
Eli Lilly and Company
 2002-02 PHASE3
NCT00498953 COMPLETED
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
 2007-05 PHASE1; PHASE2
NCT00191139 COMPLETED
Non-small Cell Lung Cancer
Eli Lilly and Company
 2003-03 PHASE2
NCT00320749 COMPLETED
Pancreatic Cancer
Tony Bekaii-Saab
 2005-12 PHASE1
NCT00577356 TERMINATED
Prostate Cancer
Benaroya Research Institute
 2008-02 PHASE2
NCT00723086 COMPLETED
Therapy, Prostatic Neoplasms
Sanofi
 2005-05 PHASE2
NCT00133224 TERMINATED
Prostate Cancer
Cell Genesys
 2005-07 PHASE3
NCT00312377 COMPLETED
Non-small Cell Lung Cancer; Lung Cancer
Genzyme, a Sanofi Company
 2006-05 PHASE3
NCT00290693 COMPLETED
Pancreatic Cancer
University of Miami
 2004-07 PHASE2
NCT00253370 COMPLETED
Adenocarcinoma of the Gastroesophageal Junction; Metastatic Gastric Cancer; Advanced Unresectable Gastric Cancer
National Cancer Institute (NCI)
 2005-10 PHASE2
NCT00266838 COMPLETED
Epiphora
Universitaire Ziekenhuizen KU Leuven
 2006-07 PHASE1
NCT00345059 TERMINATED
Advanced Non-Small Cell Lung Cancer
National Cancer Institute, Naples
 2005-05 PHASE3
NCT00354601 TERMINATED
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Wake Forest University Health Sciences
 2006-01 PHASE2
NCT02005549 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2006-02 PHASE2
NCT00243113 COMPLETED
Head and Neck Cancer
Aichi Cancer Center
 2004-06 PHASE2
NCT00343512 TERMINATED
Breast Cancer
Vanderbilt-Ingram Cancer Center
 2004-02 PHASE2
NCT00365417 COMPLETED
Breast Cancer
NSABP Foundation Inc
 2006-08 PHASE2
NCT00373204 TERMINATED
Lung Cancer
Pharmacyclics LLC.
 2006-05 PHASE2
NCT00544765 COMPLETED
Breast Cancer
GBG Forschungs GmbH
 2002-09 PHASE3
NCT00619996 COMPLETED
Prostate Cancer
Italian Trial in Medical Oncology
 2007-03 PHASE2
NCT00041067 COMPLETED
Breast Cancer
SWOG Cancer Research Network
 2002-09 PHASE2
NCT00258284 COMPLETED
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
 2003-08 PHASE2
NCT00271687 COMPLETED
Prostatic Neoplasms; Neoplasm Metastasis; Palliative Care
AHS Cancer Control Alberta
 2006-02 PHASE2
NCT00280098 COMPLETED
Prostatic Neoplasms
Sanofi
 2006-01 PHASE4
NCT00258739 COMPLETED
Lung Neoplasms
Sanofi
 2001-10 PHASE2
NCT00114192 COMPLETED
Lung Cancer
University of Virginia
 2004-06 PHASE2
NCT00315211 TERMINATED
Mediastinal Neoplasms
Aultman Health Foundation
 2004-11 PHASE2
NCT00356941 TERMINATED
Lung Cancer
Masonic Cancer Center, University of Minnesota
 2006-04 PHASE1
NCT00004125 COMPLETED
Breast Cancer
Eastern Cooperative Oncology Group
 1999-11-16 PHASE3
NCT00193271 COMPLETED
Prostate Cancer
SCRI Development Innovations, LLC
 2004-08 PHASE2
NCT00209079 TERMINATED
Gastric Adenocarcinoma
Emory University
 2004-09 PHASE2
NCT00212095 COMPLETED
Metastatic Breast Cancer
National University Hospital, Singapore
 2005-06 PHASE2
NCT00076388 COMPLETED
Non-Small-Cell Lung Carcinoma
AstraZeneca
 2004-02 PHASE3
NCT00258375 COMPLETED
Breast Cancer
NCIC Clinical Trials Group
 2005-10-21 PHASE2
NCT00050674 COMPLETED
Non-small Cell Lung Cancer
Schwartzberg, Lee, M.D.
 2001-11 PHASE2
NCT00087165 COMPLETED
Prostate Cancer
University Health Network, Toronto
 2005-01 PHASE2
NCT00055861 COMPLETED
Recurrent Breast Cancer; Stage IV Breast Cancer
National Cancer Institute (NCI)
 2002-07 PHASE2
NCT00084786 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
 2004-03 PHASE1
NCT00178269 COMPLETED
Cervix Neoplasm
University of Rochester
 2005-01 PHASE2
NCT00083083 UNKNOWN
Lung Cancer
American College of Radiology Imaging Network
 2005-03 PHASE2
NCT02748213 COMPLETED
Breast Cancer
Hoffmann-La Roche
 2002-02 PHASE2
NCT00268710 COMPLETED
Prostatic Neoplasms
Sanofi
 2004-02 PHASE2
NCT00273546 COMPLETED
Cancer
Sanofi
 1999-05 PHASE3
NCT00045448 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
 2002-04 PHASE1
NCT00047255 COMPLETED
Breast Cancer
Jonsson Comprehensive Cancer Center
 2002-05 PHASE3
NCT00005800 COMPLETED
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
 1999-04 PHASE2
NCT00165399 COMPLETED
Adenocarcinoma of the Prostate; Prostate Cancer
Dana-Farber Cancer Institute
 2004-03 PHASE2
NCT00916097 COMPLETED
Head and Neck Neoplasms
Sanofi
 2002-07 PHASE2
NCT00058448 TERMINATED
Penile Cancer
SWOG Cancer Research Network
 2004-10 PHASE2
NCT00193232 COMPLETED
Prostate Cancer
SCRI Development Innovations, LLC
 2004-05 PHASE2
NCT00059943 COMPLETED
Breast Cancer; Lung Cancer; Prostate Cancer
Memorial Sloan Kettering Cancer Center
 2002-09 PHASE2
NCT00080678 COMPLETED
Metastatic Cancer; Prostate Cancer
M.D. Anderson Cancer Center
 2003-05 PHASE2
NCT00461344 TERMINATED
Ductal Carcinoma
Sanofi
 2004-07 PHASE2
NCT00494338 TERMINATED
Metastatic Prostate Cancer
Sanofi
 2004-11 PHASE2
NCT00206453 TERMINATED
Breast Cancer
Baylor Breast Care Center
 2002-01 PHASE2
NCT00027859 COMPLETED
Prostate Cancer
Eastern Cooperative Oncology Group
 2003-10-08 PHASE3
NCT00050596 COMPLETED
Prostate Cancer
Bristol-Myers Squibb
 2002-11 PHASE2
NCT00051974 COMPLETED
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc.
 2002-12 PHASE2
NCT00193011 COMPLETED
Breast Cancer
SCRI Development Innovations, LLC
 2002-03 PHASE3
NCT00146042 COMPLETED
HER-2 Positive Metastatic Breast Cancer
University of Michigan Rogel Cancer Center
 1999-03 PHASE2
NCT00003864 COMPLETED
Esophageal Cancer
Eastern Cooperative Oncology Group
 1999-09-03 PHASE2
NCT00005810 COMPLETED
Prostate Cancer
Alliance for Clinical Trials in Oncology
 2000-03 PHASE2
NCT00256789 COMPLETED
Carcinoma, Non-Small-Cell Lung
Clinical Oncology Research Associates
 2002-09
NCT00003781 COMPLETED
Pain; Prostate Cancer
OHSU Knight Cancer Institute
 1998-12 PHASE2
NCT00004037 TERMINATED
Ovarian Cancer; Primary Peritoneal Cavity Cancer
Gynecologic Oncology Group
 1998-06 PHASE2
NCT00005857 COMPLETED
Prostate Cancer
City of Hope Medical Center
 2000-08 PHASE2
NCT00005096 COMPLETED
Prostate Cancer
Dana-Farber Cancer Institute
 1999-12 PHASE2
NCT00028873 COMPLETED
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
 2001-09 PHASE2
NCT00003587 COMPLETED
Lung Cancer
SWOG Cancer Research Network
 1998-10 PHASE2
NCT00003231 COMPLETED
Lung Cancer
Swiss Cancer Institute
 1997-04 PHASE2
NCT00004243 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
 2000-03 PHASE1
NCT00364195 COMPLETED
Metastatic Breast Cancer
YM BioSciences
 2006-06 PHASE2
NCT00080080 COMPLETED
Lung Cancer
Point Therapeutics
 PHASE2
NCT00291005 COMPLETED
Prostatic Neoplasms
Sanofi
 2004-08 PHASE2
NCT00031187 COMPLETED
Prostatic Neoplasms
Seagen Inc.
 2000-10 PHASE2
NCT00005627 COMPLETED
Prostate Cancer
Dana-Farber Cancer Institute
 1999-03 PHASE1
NCT00136526 COMPLETED
Prostate Cancer
University of Washington
 2002-12 PHASE2
NCT01685489 WITHDRAWN
Prostatic Neoplasms
Bastyr University
 2013-05 PHASE1
NCT00736814 UNKNOWN
Lung Cancer
Yonsei University
 2008-06 PHASE2
NCT00274898 UNKNOWN
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
 2004-05 PHASE2
NCT00003679 UNKNOWN
Breast Cancer
Scottish Cancer Therapy Network
 1998-11 PHASE3
NCT00095225 COMPLETED
Non-Small-Cell Lung Carcinoma; Neoplasm Recurrence, Local
Genentech, Inc.
 2004-07 PHASE2
NCT00006215 UNKNOWN
Lung Cancer
Amgen
 1999-10 PHASE2
NCT00260026 COMPLETED
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
 2004-11 PHASE2
NCT00989690 UNKNOWN
Lung Cancer
Istituto Scientifico H. San Raffaele
 2008-02 PHASE3
NCT00073385 COMPLETED
Carcinoma, Non-Small-Cell Lung
Titan Pharmaceuticals
 2003-09 PHASE2
NCT00072618 COMPLETED
NSCLC
Astellas Pharma Inc
 2001-10 PHASE1; PHASE2
NCT00319618 COMPLETED
Metastatic Breast Cancer
AstraZeneca
 2003-06 PHASE2
NCT00243204 TERMINATED
Carcinoma, Non-Small Cell Lung
Point Therapeutics
 2006-01 PHASE3
NCT00115635 COMPLETED
Prostate Cancer
Herlev Hospital
 2005-03 PHASE1; PHASE2
NCT00004923 COMPLETED
Unspecified Adult Solid Tumor, Protocol Specific
Yale University
 1999-04 PHASE1; PHASE2
NCT00510107 UNKNOWN
Stomach Neoplasm; Stage IV; Recurrent
Gachon University Gil Medical Center
 2007-07 PHASE2
NCT00155883 TERMINATED
Gastric Cancer
National Taiwan University Hospital
 2004-06 PHASE2
NCT00288002 COMPLETED
Breast Cancer
GBG Forschungs GmbH
 2005-01 PHASE3
NCT00525642 UNKNOWN
Breast Neoplasms; Adjuvant; Chemotherapy
Fudan University
 2003-06 PHASE2; PHASE3
NCT00002903 COMPLETED
Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor
European Organisation for Research and Treatment of Cancer - EORTC
 1995-07 PHASE2
NCT00115414 COMPLETED
Breast Cancer; Fever; Neutropenia
Amgen
 PHASE2
NCT00080041 COMPLETED
Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Lung Neoplasms
Pharmacyclics LLC.
 PHASE1
NCT00215748 TERMINATED
Breast Cancer; Lung Cancer
Geriatric Oncology Consortium
 2004-08 PHASE2
NCT00126230 TERMINATED
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris
 2004-01 PHASE2
NCT00290966 COMPLETED
Stomach Neoplasm
Sanofi
 1998-10 PHASE2; PHASE3
NCT00264134 TERMINATED
Non-small Cell Lung Cancer; Extensive Stage Unresectable
Kentuckiana Cancer Institute
 2003-06 PHASE1; PHASE2
NCT00103428 TERMINATED
Prostate Cancer
Cell Genesys
 2004-08 PHASE1; PHASE2
NCT00004264 UNKNOWN
Drug/Agent Toxicity by Tissue/Organ; Lung Cancer
University of Wisconsin, Madison
 1997-07 PHASE1; PHASE2

(data from https://clinicaltrials.gov, updated on 2026-09-04)

Check the Docetaxel product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Docetaxel binds directly to stabilized tubulin within microtubules and prevents microtubule disassembly, which inhibits normal mitotic spindle dynamics and leads to cell-cycle arrest at the G2/M phase followed by apoptotic cell death. By suppressing microtubule depolymerization and tumor cell proliferation, docetaxel exerts potent anti-neoplastic activity, providing therapeutic efficacy in clinical conditions such as breast, non-small cell lung, and prostate cancers.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.